CRX PHARMACEUTICALS Trademark

Trademark Overview

On Friday, February 8, 2002, a trademark application was filed for CRX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the CRX PHARMACEUTICALS trademark a serial number of 78107698. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, July 28, 2007. This trademark is owned by CombinatoRx. Inc.. The CRX PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Prescription pharmaceuticals, namely therapeutic agents and/or combination therapeutic agents for the treatment of a neoplasm, an immunoinflammatory disease, a metabolic disorder, or an infection

General Information

Serial Number78107698
Word MarkCRX PHARMACEUTICALS
Filing DateFriday, February 8, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSaturday, July 28, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 4, 2004

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPrescription pharmaceuticals, namely therapeutic agents and/or combination therapeutic agents for the treatment of a neoplasm, an immunoinflammatory disease, a metabolic disorder, or an infection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 19, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCombinatoRx. Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02412
Party NameCombinatoRx. Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02118

Trademark Events

Event DateEvent Description
Monday, December 10, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, December 7, 2007ABANDONMENT - NO USE STATEMENT FILED
Friday, August 31, 2007EXPARTE APPEAL TERMINATED
Monday, March 26, 2007EXTENSION 5 GRANTED
Wednesday, January 24, 2007EXTENSION 5 FILED
Wednesday, January 24, 2007TEAS EXTENSION RECEIVED
Tuesday, September 5, 2006EXTENSION 4 GRANTED
Tuesday, July 25, 2006EXTENSION 4 FILED
Tuesday, July 25, 2006PAPER RECEIVED
Thursday, February 23, 2006EXTENSION 3 GRANTED
Thursday, January 26, 2006EXTENSION 3 FILED
Thursday, January 26, 2006PAPER RECEIVED
Friday, August 5, 2005EXTENSION 2 GRANTED
Tuesday, July 26, 2005EXTENSION 2 FILED
Tuesday, July 26, 2005PAPER RECEIVED
Thursday, February 24, 2005EXTENSION 1 GRANTED
Tuesday, January 25, 2005EXTENSION 1 FILED
Tuesday, January 25, 2005PAPER RECEIVED
Tuesday, October 19, 2004ASSIGNED TO EXAMINER
Tuesday, September 7, 2004ASSIGNED TO EXAMINER
Tuesday, July 27, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 27, 2004PAPER RECEIVED
Tuesday, May 4, 2004PUBLISHED FOR OPPOSITION
Wednesday, April 14, 2004NOTICE OF PUBLICATION
Monday, February 23, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 13, 2004CASE FILE IN TICRS
Wednesday, February 11, 2004JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, February 11, 2004EX PARTE APPEAL-INSTITUTED
Tuesday, January 13, 2004EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, June 24, 2003FINAL REFUSAL E-MAILED
Tuesday, December 17, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 4, 2003REINSTATED
Thursday, May 8, 2003FAX RECEIVED
Friday, March 14, 2003ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 25, 2002ASSIGNED TO EXAMINER
Monday, June 17, 2002NON-FINAL ACTION E-MAILED
Thursday, June 13, 2002ASSIGNED TO EXAMINER

Related Keywords

pharmaceuticals agents therapeutic disease metabolic infection immunoinflammatory disorder treatment namely